Luke Moore to Seroepidemiologic Studies
This is a "connection" page, showing publications Luke Moore has written about Seroepidemiologic Studies.
Connection Strength
0.052
-
SARS-CoV-2 lateral flow assays for possible use in national covid-19 seroprevalence surveys (React 2): diagnostic accuracy study. BMJ. 2021 03 02; 372:n423.
Score: 0.018
-
Clinical and laboratory evaluation of SARS-CoV-2 lateral flow assays for use in a national COVID-19 seroprevalence survey. Thorax. 2020 12; 75(12):1082-1088.
Score: 0.017
-
Point-of-care serological assays for delayed SARS-CoV-2 case identification among health-care workers in the UK: a prospective multicentre cohort study. Lancet Respir Med. 2020 09; 8(9):885-894.
Score: 0.017